bavencio
(avelumab)EMD Serono, Inc.
Usage: BAVENCIO (avelumab) is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma, maintenance treatment of locally advanced or metastatic urothelial carcinoma after platinum chemotherapy, and first-line treatment of advanced renal cell carcinoma in combination with axitinib.